GW & Wade’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

GW & Wade’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$865K	Sell	5,475 -145	-3%	-$20.8K	0.03%	241
2023 Q3	$822K	Hold	5,620	–	–	0.03%	229
2023 Q2	$861K	Sell	5,620 -111	-2%	-$17.3K	0.03%	224
2023 Q1	$888K	Hold	5,731	–	–	0.03%	214
2022 Q4	$883K	Buy	5,731 +100	+2%	+$14.8K	0.04%	208
2022 Q3	$743K	Buy	5,631 +650	+13%	+$91.2K	0.04%	198
2022 Q2	$675K	Hold	4,981	–	–	0.03%	218
2022 Q1	$743K	Buy	4,981 +100	+2%	+$14.8K	0.03%	210
2021 Q4	$791K	Hold	4,881	–	–	0.03%	206
2021 Q3	$811K	Hold	4,881	–	–	0.04%	203
2021 Q2	$843K	Buy	4,881 +1,155	+31%	+$191K	0.04%	200
2021 Q1	$598K	Buy	3,726 +1,260	+51%	+$216K	0.03%	198
2020 Q4	$414K	Buy	+2,466	New	+$400K	0.03%	205

Other funds holding FBT

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

GW & Wade's FBT Position: Q4 2023 in Review

GW & Wade reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 2.6% in Q4 2023, selling an estimated $20.8K and leaving 5,475 shares worth $865K. The position accounts for 0.03% of the portfolio, ranked #241.

GW & Wade first reported a position in FBT in Q4 2020 and has held it in 13 quarters since. The position peaked at $888K in Q1 2023. 257 funds tracked by Wall St. Rank hold FBT as of Q4 2023.

GW & Wade held 5,475 shares of First Trust NYSE Arca Biotechnology Index Fund worth $865K as of Q4 2023.
GW & Wade sold 145 First Trust NYSE Arca Biotechnology Index Fund shares in Q4 2023, an estimated $20.8K.
First Trust NYSE Arca Biotechnology Index Fund made up 0.03% of GW & Wade's portfolio in Q4 2023, its #241 holding.
GW & Wade first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2020 and has held it in 13 quarters since.
GW & Wade's First Trust NYSE Arca Biotechnology Index Fund position peaked at $888K in Q1 2023.
257 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q4 2023.

Based on GW & Wade's 13F filing for Q4 2023, filed 8 Feb 2024.